These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12528302)

  • 1. Antibacterial agents: patent highlights January to June 2002.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1701-11. PubMed ID: 12528302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial agents: patent highlights July to December 2002.
    Phillips OA
    Curr Opin Investig Drugs; 2003 Feb; 4(2):117-27. PubMed ID: 12669371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial agents: patent highlights January to June 2004.
    Phillips OA
    Curr Opin Investig Drugs; 2004 Aug; 5(8):799-808. PubMed ID: 15600236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial agents: patent highlights January to June 2003.
    Phillips OA
    Curr Opin Investig Drugs; 2003 Aug; 4(8):926-36. PubMed ID: 14508876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial agents: patent highlights January 2005 to June 2005.
    Phillips OA
    Curr Opin Investig Drugs; 2005 Aug; 6(8):768-80. PubMed ID: 16121683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel heterodimer antibiotics: a review of recent patent literature.
    Long DD; Marquess DG
    Future Med Chem; 2009 Sep; 1(6):1037-50. PubMed ID: 21425993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antibacterial agents: patent applications published in 2011.
    Keating TA; Lister T; Verheijen JC
    Pharm Pat Anal; 2014 Jan; 3(1):87-112. PubMed ID: 24354981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New antibacterial agents: patent applications published in 2010.
    Stokes SS; Morningstar M; Kocis H; Verheijen JC
    Pharm Pat Anal; 2012 Nov; 1(5):601-20. PubMed ID: 24236928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The search for new antimicrobials: why we need new options.
    Zinner SH
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):907-13. PubMed ID: 16307503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
    Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
    J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present.
    Gadakh B; Van Aerschot A
    Expert Opin Ther Pat; 2012 Dec; 22(12):1453-65. PubMed ID: 23062029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxazolidinone structure-activity relationships leading to linezolid.
    Barbachyn MR; Ford CW
    Angew Chem Int Ed Engl; 2003 May; 42(18):2010-23. PubMed ID: 12746812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking inventory: antibacterial agents currently at or beyond phase 1.
    Bush K; Macielag M; Weidner-Wells M
    Curr Opin Microbiol; 2004 Oct; 7(5):466-76. PubMed ID: 15451501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products--the future scaffolds for novel antibiotics?
    Butler MS; Buss AD
    Biochem Pharmacol; 2006 Mar; 71(7):919-29. PubMed ID: 16289393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of Bacillus anthracis to various antibacterial agents and their time-kill activity.
    Athamna A; Massalha M; Athamna M; Nura A; Medlej B; Ofek I; Bast D; Rubinstein E
    J Antimicrob Chemother; 2004 Feb; 53(2):247-51. PubMed ID: 14688054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future prospects of oxazolidinones.
    Johnson AP
    IDrugs; 2003 Mar; 6(3):240-5. PubMed ID: 12789613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the more-potent antibiotics quinupristin-dalfopristin and linezolid on outcome measure of patients with vancomycin-resistant Enterococcus bacteremia.
    Erlandson KM; Sun J; Iwen PC; Rupp ME
    Clin Infect Dis; 2008 Jan; 46(1):30-6. PubMed ID: 18171210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of antibiotic patents issued in China from 1992 to 2011.
    Xie H; Zhang H; Zhang S; He S
    Expert Opin Ther Pat; 2012 Oct; 22(10):1205-32. PubMed ID: 22957903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.